Author: WTN News

The Certification Commission for Healthcare Information Technology (CCHIT)), the federally recognized body for testing and certifying electronic health records (EHRs), has announced it will develop dermatology-specific functionality criteria beginning in 2009. The CCHIT's decision was in part a response to an application from the American...

On March 2, 2009, the U.S. Supreme Court granted a writ of certiorari in Reed Elsevier, Inc. v. Muchnik This case presents a potentially crucial issue for copyright owners seeking to enforce their rights in court: Must a copyright owner obtain a copyright registration before...

Salesforce.com reaches record quarterly revenues of $290 million despite the recession, and marks more than $1 billion in revenue for the entire year, according to financial results for its fiscal fourth quarter ended Jan. 31. The cloud computing CRM specialist posted net profits of $13.75...

In the face of a challenging economy, IT organizations are under unprecedented pressure to cut costs. At the same time, they are tasked with the smooth operation of the data center, which is becoming more complex all the time as a result of continual consolidation,...

At this time with unemployment rates climbing and incomes being cut, it is more important now than ever that our State Legislature stand on the side of business and do what we can to create new jobs and prevent more businesses from closing their doors,...

After the election, I wrote enthusastically about the potential for the Obama Administration to deploy Government 2.0 by using the same tech-niques that drove the campaign. But as the Washington Post reports, the idea is running hard aground the reality of White House technology and protocol. Obama,...

Cellectar, a privately held radiopharmaceuticals company that designs and develops products to detect, treat and monitor human cancers, today announced that the U.S. Food and Drug Administration (FDA) has cleared the Company's Investigational New Drug (IND) application for its 131I-CLR1404 drug candidate for testing in...